✦ LIBER ✦
Discovery of 4-Heteroarylbicyclo[2.2.2]octyltriazoles as Potent and Selective Inhibitors of 11β-HSD1: Novel Therapeutic Agents for the Treatment of Metabolic Syndrome.
✍ Scribed by Xin Gu; et al. et al.
- Publisher
- John Wiley and Sons
- Year
- 2006
- Weight
- 15 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.